Français
ItalianoBond BioMarin Pharmaceutical 5.5% ( US09061GAL59 ) in USD
| Issuer | BioMarin Pharmaceutical | ||||||
| Market price |  100.00 % ⇌ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US09061GAL59 ( in USD )
|
||||||
| Interest rate | 5.5% per year ( payment 2 times a year) | ||||||
| Maturity | 15/02/2034 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 200 000 USD | ||||||
| Total amount | 850 000 000 USD | ||||||
| Cusip | 09061GAL5 | ||||||
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) | ||||||
| Moody's rating | Ba3 ( Non-investment grade speculative ) | ||||||
| Next Coupon | 15/02/2027 ( In 173 days ) | ||||||
| Detailed description |
American biotechnology company specializing in therapies for rare genetic diseases. The Bond issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, pays a coupon of 5.5% per year. The coupons are paid 2 times per year and the Bond maturity is 15/02/2034 The Bond issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, was rated Ba3 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by BioMarin Pharmaceutical ( United States ) , in USD, with the ISIN code US09061GAL59, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||